AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27059887 — intervention group
Group type: EXPERIMENTAL
Intervention: ixmyelocel-T
Number of subjects: 126
Study 27059887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 25266206 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein yogurt (14 g protein/25 g CHO/0 g fat)
Number of subjects: 20
Study 25266206 — intervention group
Group type: COMPARATOR
Intervention: High-fat snacks (crackers and chocolate)
Number of subjects: 20
Study 22892748 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibringe sonic irrigation technique
Number of subjects: 20
Study 22892748 — intervention group
Group type: COMPARATOR
Intervention: Side‐vented needle irrigation (SNI)
Number of subjects: 20
Study 20160003 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective ECG-triggered CT angiography (100 kV)
Number of subjects: 139
Study 20160003 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective ECG-triggered CT angiography (120 kV)
Number of subjects: 139
Study 20160003 — intervention group
Group type: COMPARATOR
Intervention: Retrospective ECG-gated helical CT angiography (100 kV)
Number of subjects: 139
Study 20160003 — intervention group
Group type: COMPARATOR
Intervention: Retrospective ECG-gated helical CT angiography (120 kV)
Number of subjects: 139
Study 20160003 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective ECG-triggered CT angiography
Number of subjects: 139
Study 20160003 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques (prospective and retrospective)
Number of subjects: 139
Study 17319368 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive resin cement (Chemiace II)
Number of subjects: 60
Study 17319368 — intervention group
Group type: COMPARATOR
Intervention: Conventional glass-ionomer cement (Ketac-Cem)
Number of subjects: 60
Study 15337553 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral aloe vera gel
Number of subjects: 58
Study 15337553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 11136207 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive disorders (diagnosed using GMS-AGECAT)
Number of subjects: 1500
Study 11136207 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-demographic correlates and life events
Number of subjects: 1500
Study 9647159 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium hydroxide
Number of subjects: 40
Study 9647159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 8024092 — intervention group
Group type: EXPERIMENTAL
Intervention: Bassini with absorbable sutures (polyglycolic acid)
Number of subjects: 750
Study 8024092 — intervention group
Group type: COMPARATOR
Intervention: Bassini with nonabsorbable sutures (polyester)
Number of subjects: 750
Study 8024092 — intervention group
Group type: EXPERIMENTAL
Intervention: Shouldice with four rows of polypropylene sutures
Number of subjects: 750
Study 8024092 — intervention group
Group type: EXPERIMENTAL
Intervention: Shouldice with two rows of polypropylene sutures
Number of subjects: 750
Study 8024092 — intervention group
Group type: EXPERIMENTAL
Intervention: Shouldice technique
Number of subjects: 750
Study 8024092 — intervention group
Group type: EXPERIMENTAL
Intervention: Omitting permanent muscle sutures (groups A and D)
Number of subjects: 750
Study 2642754 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (40 mg/day)
Number of subjects: 17
Study 2642754 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol (500 mg b.i.d.)
Number of subjects: 17
Study 2642754 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin plus colestipol (10 g b.i.d.)
Number of subjects: 17
Study 2642754 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (80 mg/day) plus colestipol (10 g b.i.d.)
Number of subjects: 17
Study 2642754 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin plus probucol
Number of subjects: 17
Study 2642754 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol
Number of subjects: 17
Study 2642754 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 17
Study 797258 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofibrate
Number of subjects: 12
Study 797258 — intervention group
Group type: EXPERIMENTAL
Intervention: Halofenate
Number of subjects: 12
Study 797258 — intervention group
Group type: COMPARATOR
Intervention: Clofibrate and Halofenate
Number of subjects: 12
Study 30744679 — intervention group
Group type: EXPERIMENTAL
Intervention: Edelvaiss® Multiline NEO device
Number of subjects: 280
Study 30744679 — intervention group
Group type: COMPARATOR
Intervention: Standard infusion system
Number of subjects: 280
Study 29042645 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal insulin
Number of subjects: 0
Study 29042645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29042645 — intervention group
Group type: EXPERIMENTAL
Intervention: Water administration
Number of subjects: 0
Study 26963178 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention addressing common prejudices via scientific evidence and prerecorded audio-testimony from PWS; duration: two 3-hr sessions a week apart
Number of subjects: 188
Study 26963178 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 188
Study 25086122 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression using ankle injury stockings (AIS) plus an Aircast boot
Number of subjects: 90
Study 25086122 — intervention group
Group type: COMPARATOR
Intervention: Tubigrip plus an Aircast boot
Number of subjects: 90
Study 21800228 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartoon-based hostile attributional bias measure
Number of subjects: 0
Study 21800228 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest reliability trial of the adapted measure
Number of subjects: 0
Study 19617456 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed of processing intervention (vs. no-contact control)
Number of subjects: 2030
Study 19617456 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 2030
Study 17697100 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholinesterase inhibitor therapy (ChEI)
Number of subjects: 28961
Study 14995919 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (n = 37), stimulated once or twice a week until delivery or complete recovery
Number of subjects: 72
Study 14995919 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 35), no sham stimulation
Number of subjects: 72
Study 14995919 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (n = 37)
Number of subjects: 72
Study 11994555 — intervention group
Group type: EXPERIMENTAL
Intervention: GPIIb/IIIa antagonist, orbofiban
Number of subjects: 1014
Study 9871430 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 10
Study 7591344 — intervention group
Group type: EXPERIMENTAL
Intervention: Raising the drinking age laws in New York State in the 1980s
Number of subjects: 0
Study 7591344 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial beginning drinkers
Number of subjects: 0
Study 2334579 — intervention group
Group type: EXPERIMENTAL
Intervention: Antispasmodic (otilonium)
Number of subjects: 86
Study 2334579 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranquilizer (clobazam)
Number of subjects: 86
Study 371737 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and pyloroplasty
Number of subjects: 149
Study 371737 — intervention group
Group type: COMPARATOR
Intervention: Highly selective vagotomy
Number of subjects: 149
Study 31907854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 30137547 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib modified-release (MR) 11 mg once daily (QD)
Number of subjects: 209
Study 30137547 — intervention group
Group type: COMPARATOR
Intervention: Tofacitinib immediate-release (IR) 5 mg twice daily (BID)
Number of subjects: 209
Study 30137547 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations (MR and IR)
Number of subjects: 209
Study 28012081 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroplasty
Number of subjects: 136
Study 28012081 — intervention group
Group type: COMPARATOR
Intervention: Fusion
Number of subjects: 136
Study 25830242 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse home visitation program
Number of subjects: 460
Study 25830242 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 460
Study 24216486 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive shared reading with a character that fits conceptually with carrots (rabbit)
Number of subjects: 104
Study 24216486 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive reading with a character that fits conceptually with carrots (rabbit)
Number of subjects: 104
Study 24216486 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive shared reading with a character that does not fit conceptually with carrots (turtle)
Number of subjects: 104
Study 24216486 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive reading with a character that does not fit conceptually with carrots (turtle)
Number of subjects: 104
Study 24216486 — intervention group
Group type: COMPARATOR
Intervention: Baseline group (not exposed to the book)
Number of subjects: 104
Study 22496156 — intervention group
Group type: EXPERIMENTAL
Intervention: Apheresis platelets
Number of subjects: 1272
Study 22496156 — intervention group
Group type: EXPERIMENTAL
Intervention: ABO-identical platelets
Number of subjects: 1272
Study 22496156 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelets stored for 3 days
Number of subjects: 1272
Study 22496156 — intervention group
Group type: COMPARATOR
Intervention: Randomized dose strategy, platelet source, ABO compatibility, and duration of storage
Number of subjects: 1272
Study 22496156 — intervention group
Group type: COMPARATOR
Intervention: Overall platelet transfusion
Number of subjects: 1272
Study 18815438 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed amphetamine salts-extended release (MAS XR) 50 mg/day
Number of subjects: 19
Study 18815438 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine 80 mg/day
Number of subjects: 19
Study 18815438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 17522240 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiation therapy
Number of subjects: 0
Study 17522240 — intervention group
Group type: COMPARATOR
Intervention: Abdominoperineal resection
Number of subjects: 0
Study 16021360 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mcg IFNbeta‐1b every other day
Number of subjects: 695
Study 12499477 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 40
Study 12499477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9810560 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiphospholipid antibodies positivity in children with partial seizures
Number of subjects: 23
Study 8702064 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous force (50 cN, reactivated weekly for 4 and 7 weeks)
Number of subjects: 16
Study 8702064 — intervention group
Group type: COMPARATOR
Intervention: Interrupted continuous force (50 cN, uncontrolled for 3 weeks, then passive for 1 week)
Number of subjects: 16
Study 2618318 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine hydrochloride anaesthesia applied intravenously
Number of subjects: 0
Study 2618318 — intervention group
Group type: COMPARATOR
Intervention: Halothane inhalation anaesthesia in combination with nitrous oxide and oxygen
Number of subjects: 0
Study 383272 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/m2 q 3 wk
Number of subjects: 113
Study 383272 — intervention group
Group type: COMPARATOR
Intervention: 200 mg/m2 q 6 wk
Number of subjects: 113
Study 31218992 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training program (12 weeks)
Number of subjects: 30
Study 31218992 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study 27941245 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion after 6 weeks of storage
Number of subjects: 60
Study 27941245 — intervention group
Group type: COMPARATOR
Intervention: Transfusion after 1 to 5 weeks of storage
Number of subjects: 60
Study 25671254 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib (24 mg per day in 28-day cycles)
Number of subjects: 392
Study 25671254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study 23083331 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric exercise combined with high intensity weight training (90-95% of maximum muscle strength)
Number of subjects: 0
Study 23083331 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric exercise combined with low intensity weight training (60% of maximum muscle strength)
Number of subjects: 0
Study 23083331 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 0
Study 22267138 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical appointment with educational intervention (Group B)
Number of subjects: 120
Study 22267138 — intervention group
Group type: COMPARATOR
Intervention: Routine medical appointment (Group A)
Number of subjects: 120
Study 22267138 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 120
Study 19231158 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated pretreatment neutrophil count (cut-off value 4500 mm(‐3))
Number of subjects: 388
Study 19231158 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pretreatment neutrophil count (below 4500 mm(‐3))
Number of subjects: 388
Study 19231158 — intervention group
Group type: EXPERIMENTAL
Intervention: High pretreatment neutrophil count (above 4500 mm(‐3))
Number of subjects: 388
Study 16762345 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrification
Number of subjects: 508
Study 16762345 — intervention group
Group type: COMPARATOR
Intervention: Slow-freezing
Number of subjects: 508
Study 16938062 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive impairment
Number of subjects: 1726
Study 16938062 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 1726
Study 16938062 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholics Anonymous Involvement
Number of subjects: 1726
Study 14646680 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost once daily
Number of subjects: 268
Study 14646680 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol twice daily
Number of subjects: 268
Study 10760337 — intervention group
Group type: EXPERIMENTAL
Intervention: bosentan (1 g twice daily; n = 18)
Number of subjects: 30
Study 10760337 — intervention group
Group type: COMPARATOR
Intervention: placebo (n = 12)
Number of subjects: 30
Study 9275638 — intervention group
Group type: EXPERIMENTAL
Intervention: Teprenone
Number of subjects: 98
Study 1996894 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg daily for six days
Number of subjects: 121
Study 1996894 — intervention group
Group type: COMPARATOR
Intervention: 0.2 mg/kg every 12 hours for three doses
Number of subjects: 121
Study 6648735 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg/d
Number of subjects: 37
Study 6648735 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg plus triamterene 50 mg
Number of subjects: 37
Study 6648735 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride hydrochloride 5 mg plus hydrochlorothiazide 50 mg
Number of subjects: 37
Study 6648735 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone 50 mg/d
Number of subjects: 37
Study 6648735 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide 2.5 mg/d
Number of subjects: 37
Study 6648735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 30792142 — intervention group
Group type: EXPERIMENTAL
Intervention: Procyanidin supplementation (100 mg during a meal)
Number of subjects: 40
Study 30792142 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two capsules during a meal)
Number of subjects: 40
Study 30792142 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-rich meal (43 mg of iron)
Number of subjects: 40
Study 29258716 — intervention group
Group type: EXPERIMENTAL
Intervention: FreeStyle Libre
Number of subjects: 22
Study 29258716 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexcom G4 Platinum
Number of subjects: 22
Study 29258716 — intervention group
Group type: COMPARATOR
Intervention: Both sensors
Number of subjects: 22
Study 28279994 — intervention group
Group type: EXPERIMENTAL
Intervention: PreHomeCare (early inhomecare with video consultations and mobile applications)
Number of subjects: 160
Study 28279994 — intervention group
Group type: COMPARATOR
Intervention: Usual care (in-hospital consultations)
Number of subjects: 160
Study 25544294 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine plus dexmedetomidine solution
Number of subjects: 20
Study 25544294 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine solution
Number of subjects: 20
Study 24064339 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (60 min/day for 5 days/wk at ∼85% HRmax for 12 weeks)
Number of subjects: 24
Study 24064339 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 24
Study 21443422 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (2 g twice a day for 90 days)
Number of subjects: 67
Study 21443422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 18163521 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous methotrexate (15 mg/week for 24 weeks)
Number of subjects: 375
Study 18163521 — intervention group
Group type: COMPARATOR
Intervention: Oral methotrexate (15 mg/week for 24 weeks)
Number of subjects: 375
Study 18163521 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous methotrexate (15 mg/week switched to 20 mg/week for 8 weeks)
Number of subjects: 375
Study 18163521 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous methotrexate (20 mg/week for 8 weeks)
Number of subjects: 375
Study 16928786 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 50 mg
Number of subjects: 11
Study 16928786 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 100 mg
Number of subjects: 11
Study 16928786 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg
Number of subjects: 11
Study 16928786 — intervention group
Group type: COMPARATOR
Intervention: Control (fexofenadine alone)
Number of subjects: 11
Study 15319645 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole, amoxycillin and clarithromycin (n = 10)
Number of subjects: 20
Study 15319645 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole and 2 placebos (n = 10)
Number of subjects: 20
Study 15319645 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (triple treatment and placebo)
Number of subjects: 20
Study 11007083 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX) treatment
Number of subjects: 0
Study 9173954 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO supplement (1 g/kg) immediately postexercise
Number of subjects: 8
Study 9173954 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO supplement (1 g/kg) 1 h postexercise
Number of subjects: 8
Study 9173954 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl) immediately postexercise
Number of subjects: 8
Study 9173954 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl) 1 h postexercise
Number of subjects: 8
Study 8141712 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) with subcutaneous heparin
Number of subjects: 41021
Study 8141712 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) and intravenous heparin
Number of subjects: 41021
Study 8141712 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated tissue plasminogen activator (t‐PA) and intravenous heparin
Number of subjects: 41021
Study 8141712 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined SK and t‐PA
Number of subjects: 41021
Study 3099002 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex and elemental enteral formulas at infusion rates of 50 to 150 kcal/hr
Number of subjects: 20
Study 3099002 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex and elemental enteral formulas at osmolalities of 325 to 690 mOsm/Kg of water
Number of subjects: 20
Study 28728683 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional HF treatment combined with an individualized nutritional intervention
Number of subjects: 120
Study 28728683 — intervention group
Group type: COMPARATOR
Intervention: Conventional HF treatment
Number of subjects: 120
Study 27413123 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium gluconate (20, 40, 60 mEq K/d)
Number of subjects: 35
Study 27413123 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfried potatoes (20, 40, 60 mEq K/d)
Number of subjects: 35
Study 27413123 — intervention group
Group type: EXPERIMENTAL
Intervention: French fries (40 mEq K)
Number of subjects: 35
Study 27413123 — intervention group
Group type: COMPARATOR
Intervention: Control (0 mEq K/d)
Number of subjects: 35
Study 25752116 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate cream combined with He-Ne laser irradiation treatment
Number of subjects: 200
Study 25752116 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate cream treatment
Number of subjects: 200
Study 22094904 — intervention group
Group type: EXPERIMENTAL
Intervention: BMMSC treatment
Number of subjects: 100
Study 22094904 — intervention group
Group type: COMPARATOR
Intervention: Core decompression (CD) treatment
Number of subjects: 100
Study 22094904 — intervention group
Group type: EXPERIMENTAL
Intervention: BMMSC treatment and CD treatment
Number of subjects: 100
Study 20838642 — intervention group
Group type: EXPERIMENTAL
Intervention: SP‐IPTi
Number of subjects: 7
Study 18757480 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + LBNP (Ex-LBNP)
Number of subjects: 24
Study 18757480 — intervention group
Group type: COMPARATOR
Intervention: Control (Con)
Number of subjects: 24
Study 18757480 — intervention group
Group type: COMPARATOR
Intervention: Nutrition (Nut)
Number of subjects: 24
Study 18757480 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonfinishers (NF)
Number of subjects: 24
Study 18757480 — intervention group
Group type: EXPERIMENTAL
Intervention: Finishers
Number of subjects: 24
Study 18757480 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 24